학술논문

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors
Document Type
Journal
Source
BMJ OPEN; MAR 2022, 12 3, pe057018 7p.
Subject
Language
English
ISSN
20446055